147 related articles for article (PubMed ID: 11004662)
1. K-ras point mutation is associated with enhancement by deoxycholic acid of colon carcinogenesis induced by azoxymethane, but not with its attenuation by all-trans-retinoic acid.
Narahara H; Tatsuta M; Iishi H; Baba M; Uedo N; Sakai N; Yano H; Ishiguro S
Int J Cancer; 2000 Oct; 88(2):157-61. PubMed ID: 11004662
[TBL] [Abstract][Full Text] [Related]
2. Modulation of azoxymethane-induced mutational activation of ras protooncogenes by chemopreventive agents in colon carcinogenesis.
Singh J; Kulkarni N; Kelloff G; Reddy BS
Carcinogenesis; 1994 Jul; 15(7):1317-23. PubMed ID: 8033306
[TBL] [Abstract][Full Text] [Related]
3. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J
J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579
[TBL] [Abstract][Full Text] [Related]
4. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by a xanthine oxidase inhibitor, 1'-acetoxychavicol acetate.
Tanaka T; Kawabata K; Kakumoto M; Makita H; Matsunaga K; Mori H; Satoh K; Hara A; Murakami A; Koshimizu K; Ohigashi H
Jpn J Cancer Res; 1997 Sep; 88(9):821-30. PubMed ID: 9369929
[TBL] [Abstract][Full Text] [Related]
5. Enhancement by thyroxine of experimental carcinogenesis induced in rat colon by azoxymethane.
Iishi H; Tatsuta M; Baba M; Okuda S; Taniguchi H
Int J Cancer; 1992 Apr; 50(6):974-6. PubMed ID: 1555896
[TBL] [Abstract][Full Text] [Related]
6. Dietary fat and colon cancer: modulating effect of types and amount of dietary fat on ras-p21 function during promotion and progression stages of colon cancer.
Singh J; Hamid R; Reddy BS
Cancer Res; 1997 Jan; 57(2):253-8. PubMed ID: 9000564
[TBL] [Abstract][Full Text] [Related]
7. ras p21 Isoprenylation inhibition induces flat colon tumors in Wistar rats.
Iishi H; Tatsuta M; Baba M; Yano H; Sakai N; Uehara H; Nakaizumi A
Dis Colon Rectum; 2000 Jan; 43(1):70-5. PubMed ID: 10813127
[TBL] [Abstract][Full Text] [Related]
8. Synergistic suppression of azoxymethane-induced foci of colonic aberrant crypts by the combination of beta-carotene and perilla oil in rats.
Komaki C; Okuno M; Onogi N; Moriwaki H; Kawamori T; Tanaka T; Mori H; Muto Y
Carcinogenesis; 1996 Sep; 17(9):1897-901. PubMed ID: 8824511
[TBL] [Abstract][Full Text] [Related]
9. Enhancement by peptide histidine isoleucine of experimental carcinogenesis in the colon of rats induced by azoxymethane.
Iishi H; Tatsuta M; Baba M; Iseki K; Uehara H; Nakaizumi A
Cancer Lett; 1995 Jul; 94(1):49-54. PubMed ID: 7621444
[TBL] [Abstract][Full Text] [Related]
10. Chemoprevention by amiloride of experimental carcinogenesis in rat colon induced by azoxymethane.
Tatsuta M; Iishi H; Baba M; Uehara H; Nakaizumi A
Carcinogenesis; 1995 Apr; 16(4):941-2. PubMed ID: 7728977
[TBL] [Abstract][Full Text] [Related]
11. Molecular markers in chemoprevention of colon cancer. Inhibition of expression of ras-p21 and p53 by sulindac during azoxymethane-induced colon carcinogenesis.
Singh J; Reddy BS
Ann N Y Acad Sci; 1995 Sep; 768():205-9. PubMed ID: 8526349
[No Abstract] [Full Text] [Related]
12. Carcinogen and dietary lipid regulate ras expression and localization in rat colon without affecting farnesylation kinetics.
Davidson LA; Lupton JR; Jiang YH; Chapkin RS
Carcinogenesis; 1999 May; 20(5):785-91. PubMed ID: 10334194
[TBL] [Abstract][Full Text] [Related]
13. Dietary seed oil rich in conjugated linolenic acid from bitter melon inhibits azoxymethane-induced rat colon carcinogenesis through elevation of colonic PPARgamma expression and alteration of lipid composition.
Kohno H; Yasui Y; Suzuki R; Hosokawa M; Miyashita K; Tanaka T
Int J Cancer; 2004 Jul; 110(6):896-901. PubMed ID: 15170673
[TBL] [Abstract][Full Text] [Related]
14. Inhibition by the dopamine antagonist haloperidol of experimental carcinogenesis induced by azoxymethane in rat colon.
Iishi H; Baba M; Tatsuta M; Okuda S; Taniguchi H
Cancer Res; 1991 Nov; 51(22):6150-2. PubMed ID: 1657380
[TBL] [Abstract][Full Text] [Related]
15. Enhancement by methionine enkephalin of colon carcinogenesis induced by azoxymethane.
Iishi H; Tatsuta M; Baba M; Okuda S; Taniguchi H
Cancer Res; 1991 Feb; 51(3):785-8. PubMed ID: 1988118
[TBL] [Abstract][Full Text] [Related]
16. Enhancement by vasoactive intestinal peptide of experimental carcinogenesis induced by azoxymethane in rat colon.
Iishi H; Tatsuta M; Baba M; Okuda S; Taniguchi H
Cancer Res; 1987 Sep; 47(18):4890-3. PubMed ID: 3621182
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of experimental colon cancer by genistein.
Rao CV; Wang CX; Simi B; Lubet R; Kelloff G; Steele V; Reddy BS
Cancer Res; 1997 Sep; 57(17):3717-22. PubMed ID: 9288778
[TBL] [Abstract][Full Text] [Related]
18. Detection of K-ras mutations in azoxymethane-induced aberrant crypt foci in mice using LNA-mediated real-time PCR clamping and mutant-specific probes.
Hu Y; Le Leu RK; Young GP
Mutat Res; 2009; 677(1-2):27-32. PubMed ID: 19442760
[TBL] [Abstract][Full Text] [Related]
19. Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1.
Bissonnette M; Khare S; von Lintig FC; Wali RK; Nguyen L; Zhang Y; Hart J; Skarosi S; Varki N; Boss GR; Brasitus TA
Cancer Res; 2000 Aug; 60(16):4602-9. PubMed ID: 10969813
[TBL] [Abstract][Full Text] [Related]
20. Transgenic expression of human MGMT protects against azoxymethane-induced aberrant crypt foci and G to A mutations in the K-ras oncogene of mouse colon.
Zaidi NH; Pretlow TP; O'Riordan MA; Dumenco LL; Allay E; Gerson SL
Carcinogenesis; 1995 Mar; 16(3):451-6. PubMed ID: 7697797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
